Wife of Ebonyi State Governor, Mary-Maudaline Nwifuru has commended the management of David Umahi Federal University of Health Sciences (DUFUHS) for building and equipping an ultra modern eye centre ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Our brain and eyes can play tricks on us—not least when it comes to the expanding hole illusion. A new computational model ...

Led by Dr. Nishant Kumar, the initiative offers tests, prescription glasses, and awareness to combat diabetes-induced ...

A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.

The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

I am a 67-year-old male with generally good vision. I have had a few floaters in my eyes over the years, but they have generally been small ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found.